Anthony Mire-SluisHead of Global Quality at AstraZeneca
Dr Mire-Sluis is currently Head of Global Quality at AstraZeneca. He was previously Vice President, Quality at Amgen Inc. Prior to working at Amgen, he was Principal Advisor, OBP, CDER and Head of Analytical Sciences and Standards, Office of the Director, CBER, FDA. He was Director of BioAnalytical Sciences at Genentech prior to joining FDA. Dr Mire-Sluis was the Head of the Cytokine Group at NIBSC in the UK. He trained in Genetics and Biometry and has a PhD in Cell biology and Biochemistry.
Dr Mire-Sluis specialized in the development of assays for the characterization and quantitation of biological products. He then became Director of BioAnalytical Sciences at Genentech and prior to joining FDA, was Executive Director of Analytical Sciences at CancerVax Corporation, San Diego.
Digitally Uplifting Quality to Advance Product Supply and Create Competitive AdvantageOn Demand - Premium OnlyView Session